Feb 3, 2026 09:11AM
Feb 3, 2026 09:10AM
Aug 7, 2025 04:01PM
May 12, 2025 06:26PM
Mar 17, 2025 04:01PM
Dec 31, 2024 05:43AM
Aug 6, 2024 04:01PM Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2024 Financial Results
Nov 6, 2023 06:04AM
Aug 8, 2023 04:01PM
Apr 27, 2023 05:17AM
Apr 26, 2023 05:28PM
Aug 31, 2021 08:30AM
Mar 18, 2021 06:26AM
Mar 3, 2021 06:17AM UPDATE: Sangamo BioSciences (SGMO) PT Lowered to $29 but Wells Fargo Sees Significant Upside Potential
Sep 2, 2020 04:15PM
Aug 30, 2019 08:30AM
Apr 8, 2019 04:01PM
Apr 4, 2019 08:03AM
Apr 4, 2019 08:00AM
Apr 3, 2019 04:01PM
Apr 3, 2019 04:01PM Sangamo Therapeutics Announces Proposed Public Offering of Common Stock
Feb 7, 2019 12:57PM
Aug 30, 2018 08:07AM
Aug 30, 2018 08:00AM
Feb 22, 2018 12:23PM
Sep 5, 2017 08:14AM
Aug 30, 2017 04:01PM
Jun 26, 2017 04:05PM Sangamo Therapeutics Announces Closing Of Public Offering Of Common Stock And Exercise In Full Of Underwriters' Option To Purchase Additional Shares Of Common Stock
Jun 21, 2017 08:27AM
Jun 21, 2017 08:26AM
Jun 20, 2017 04:01PM
Jun 20, 2017 04:01PM
May 16, 2017 09:24AM
Aug 31, 2016 04:03PM
Aug 31, 2016 04:03PM Sangamo BioSciences Announces Participation At Upcoming Investor Conferences
Dec 3, 2015 05:23PM

82,806 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All